To develop and assess a coordinated model of care for eVective management of genital chlamydial infection in young women, identified through a selective screening programme in a community based teenage health clinic. Methods: Selective screening for genital Chlamydia trachomatis was undertaken among young women aged 13-19 years who were having a routine cervical smear test, being referred for termination of pregnancy, or who reported behavioural risk factors for, and/or symptoms of, genital infection. Collaboration among family planning, genitourinary medicine (GUM), and public health staV was used to enhance management of infected individuals, with particular focus on partner notification. Results: 94 young women had confirmed genital chlamydial infection, representing 11% of those tested. All index patients received appropriate antibiotic therapy and follow up; 93 (99%) of these were counselled by a health adviser, of whom 62 (66%) were able to provide suYcient details for partner notification, resulting in treatment of male partners associated with 51 (82%) of these young women. Younger age (<16 years) was significantly associated with delay in attending for treatment. Conclusions: EVective management of genital chlamydial infection is achievable in settings outside GUM clinics using a collaborative approach which incorporates cross referencing between community based services and GUM clinics. (Sex Transm Inf 1999;75:156-161) 
Introduction
Recently, attention has focused on the debate concerning the need to introduce screening programmes for the control and prevention of Chlamydia trachomatis infections among sexually active women in the United Kingdom. Genital chlamydia infection rates for women attending genitourinary medicine (GUM) clinics in England and Wales peak among women aged 16-24 years, especially those aged 16-19 years. 1 Similarly, recent cross sectional surveys of asymptomatic women (in the United Kingdom) attending general practices, 2 and those counselled for termination of pregnancy, 3 have shown young age (<20 years) to be associated with the highest prevalence of chlamydial infection. This provides cause for concern since adolescent females may be at greater risk of developing sequelae than older women following chlamydial infection. 4 However, it has been estimated that only 10% of genital chlamydial infections in the United Kingdom are identified in GUM clinics, while the majority of such infections are likely to be asymptomatic and may be broadly distributed among young people within the general population, particularly women aged 16-19 years. 5 This highlights the need for eVorts to target young sexually active women for selective screening for C trachomatis in a range of diVerent settings.
Partner notification (also referred to as contact tracing) forms an integral part of the prevention, management, and control of sexually transmitted diseases, and is particularly important in relation to C trachomatis because of the high proportion of asymptomatic cases. 5 The aim of partner notification is to reduce the burden of asymptomatic disease in the community and shorten the average period of infectiousness for a given disease, with a view to a reduction of disease transmission within the population. 6 7 Traditionally, patients attending GUM clinics have been the initial focus for such eVorts, although partner notification for chlamydia has, in general, not been aVorded the same priority as gonorrhoea, 8 and there are no national guidelines available as there are for syphilis and gonorrhoea. 4 Where partner notification has been undertaken for cases of chlamydia diagnosed in community settings in the United Kingdom, this has achieved limited success. 9 10 There is clearly a need for selective screening programmes for chlamydia to include partner notification for eVective management of infected individuals. Such a strategy has been identified as an essential component of a new UK pilot programme for chlamydia screening in community based settings. 11 12 There have, however, been few published reports which have examined the feasibility of partner notification and its impact on health services in settings outside GUM clinics. 4 This paper describes a model of care for eVective management of chlamydial infection, detected through selective screening and based upon collaboration between staV working in a community family planning clinic for teenagers (the "teen-age" clinic), the department of genitourinary medicine, the Public Health Laboratory Service (PHLS), and the school nursing service.
Methods
Selective screening for chlamydial infection was undertaken between June 1995 and June 1997, among females aged 13-19 years who were attending a city centre teenage clinic for contraceptive care. 13 Before introduction of the screening programme, an education and training session about genital chlamydial infection was provided for all family planning staV by the department of genitourinary medicine. Screening criteria were defined in a protocol as follows: all females aged 13-19 years who were either having a cervical smear, or who were being referred for termination of pregnancy (TOP) were included. Additionally, any other females within this age group who fulfilled two or more of the following criteria were oVered screening for chlamydia-women who had been sexually active for at least 9 months; had engaged in unprotected sexual intercourse with a new partner within the past 3 months; had two or more diVerent sexual partners in the past 12 months; suspected a recent sexual partner of having other sexual partners in addition to herself; or reported intermenstrual bleeding not associated with use of the progesterone only contraceptive pill and/or symptoms of genital infection. Women who had taken antibiotics in the past 3 weeks were not included in the study, and were reassessed at their next clinic visit.
Guidelines for undertaking chlamydia tests, procedures for informing women with positive test results, treatment options, and appropriate contact tracing were included in the protocol. Family planning nurses determined eligibility for screening during the routine consultation with clinic attenders, using a specifically designed registration form for an initial 3 month period, and thereafter using a screening checklist.
Young women who were eligible for screening received verbal and written information about C trachomatis from a family planning nurse who then obtained written informed consent for testing and notification of positive test results to the local GUM clinic. Full explanation about the meaning of confidentiality was provided for all women, and reassurance given that confidentiality was a fundamental tenet of care provided by GUM clinics. In addition, the nurse clarified and documented a mutually agreed method of contact in the event of a positive test result. Following consultation with the nurse, all eligible women were then seen by a family planning doctor who checked that they had received verbal and written information about chlamydia, understood this information, and that consent for testing had been obtained. An endocervical swab (including the internal os) was taken according to the manufacturers' instructions and placed immediately in transport medium supplied in the test kit (IDEIA Chlamydia Specimen Collection Kit, Dako Diagnostics Ltd). All specimens were refrigerated and tested within 4 days of collection, and a fast track reporting system for test results was implemented by the local PHLS laboratory.
Direct fluorescent antibody (DFA) testing was used to confirm all positive test results. Where other genital infections were suspected from clinical examination and the sexual history of the patient, referral to the local GUM clinic was recommended by the doctor. If this was not acceptable to the patient, additional endocervical and vaginal swabs were taken at the teenage clinic to establish or exclude a diagnosis of candidiasis, trichomoniasis, and/or gonorrhoea.
Coordination and routine administration of the screening programme was undertaken by a designated family planning nurse coordinator who was also responsible for liaison between the teenage clinic and GUM clinic in relation to women with positive test results. All women who tested positive for chlamydia were immediately contacted by the clinic nurse coordinator by telephone or letter to an appropriate contact address, with an appointment to reattend the teenage clinic. In cases where no correspondence had been requested owing to concerns about confidentiality, other mutually agreed contact methods were used, including telephone calls to a named friend or contact via the school nursing service. Upon reattendance at the clinic, a doctor explained the test result and need for treatment and follow up. Women were oVered treatment at the teenage clinic, or referral to the GUM clinic.
Women who chose to attend the teenage clinic for treatment were provided with appropriate antibiotic treatment by a family planning doctor (oxytetracycline 500 mg, or erythromycin 500 mg four times a day for 7 days); where low compliance was expected or there was an urgent need for treatment before termination of pregnancy, a single dose of azithromycin (1 g) was given. An information sheet for patients about antibiotic treatment was also provided.
Counselling about the implications of chlamydial infection and the need for partner notification was provided for all females with a positive test result by a designated health adviser from the GUM clinic, who attended the teenage clinic for one session each fortnight, specifically for this purpose. During this initial discussion which included sexual health education, counselling and information about chlamydia, advice about treatment, and the need for sexual abstinence or the use of condoms, the method of partner notification was agreed.
The options were: patient referral of sexual contacts to the GUM clinic or general practitioner; provider referral undertaken by the health adviser; or conditional referral where initial attempts by the index patient were supplemented by the health adviser if no progress had been made by the follow up visit. Women were asked to return to the clinic for reassessment 1 week after completing their antibiotic treatment, and advised that if they did not attend for this appointment, the GUM clinic would be notified. Each index patient was also given advice about the risk of exposure to other sexually transmitted infections (STIs) and were encouraged to take advantage of comprehensive screening at the GUM clinic; if women chose to take advantage of this service they were encouraged to attend the GUM clinic for their follow up appointment in order that screening for other STIs could be undertaken at the same time.
At the follow up appointment antibiotic compliance was checked, a family planning doctor took another sample for chlamydial testing where appropriate, and the health adviser checked what action had been taken in relation to partner notification. Where no action had been taken, consent was obtained for appropriate details to be sent to the GUM clinic with liaison provided by the designated health adviser. Action was considered complete when the following criteria were met: (a) the patient had attended for treatment (b) follow up with test of cure undertaken where appropriate (c) contact tracing had been discussed and arranged by the health adviser (d) the woman's partner(s) had been treated at the GUM clinic or elsewhere. Frequent liaison between the clinic nurse coordinator and health adviser was necessary to monitor progress related to clinic attendance, treatment compliance, follow up, and contact tracing. The patient care pathway is summarised in figure 1 .
The outcome of contact tracing for index patients identified through the teenage clinic screening initiative was compared with that for a simple random sample of female GUM clinic attenders aged 20 years or younger and diagnosed with genital chlamydial infection between June 1995 and June 1997, excluding referrals from the teenage clinic. Interventions to contact sexual partners of index patients were undertaken in accordance with GUM clinic protocols. The number of interventions for contact tracing was therefore the same at both teenage and GUM clinics. Using information from the GUM clinic database, a list of 493 eligible female index patients was prepared, from which a random sample of 94 females was selected using computer generated random numbers. The clinic records for the sample were examined to determine the outcome of follow up and contact tracing.
Results
A total of 2667 attendances at the teenage clinic were made by females aged 13-19 for contraceptive care and advice during the study period. The total number of attendees who had an endocervical swab taken for chlamydial testing was 857 (excluding tests of cure), of whom 94 had a confirmed positive result, representing 11% (CI 8.88-13.06) of those tested. Each one of these attendees received appropriate antibiotic therapy, and all except one (subsequently serving a custodial sentence) were counselled by a health adviser at the teenage clinic following diagnosis. Each female with confirmed chlamydial infection was contacted and asked to return to the teenage clinic to discuss their test result and options for treatment. The majority, n = 73 (77%), chose to receive treatment and test of cure where appropriate at the teenage clinic, while 13 (14%) attended the local GUM clinic, and the remaining eight (8%) chose to attend elsewhere for treatment and follow up (see table 1 ).
Among the 94 index patients, 62 (66%) provided suYcient details of their sexual partners for contact tracing, which subsequently resulted in treatment of 51 partners (82%) associated with these women. The remaining 32 women were unable or refused to provide details of their sexual partners. Action was said to be complete for 48 (51%) index patients. Examination of GUM clinic records for the random sample of females aged 20 years or younger was undertaken for 90 patients (four sets of records were unavailable), of whom 71 (79%) provided suYcient details for contact tracing. This had resulted in treatment of 51 contacts (72%), with action complete for 36 (40%) of female index patients. Other infections were diagnosed in addition to chlamydia for seven women (four gonorrhoea, three candida), five of whom chose the GUM clinic for treatment and test of cure, and two women with gonorrhoea who preferred treatment at the teenage clinic. Among male sexual contacts who attended the GUM clinic, the following diagnoses were made: definitive C trachomatis (n = 10), gonorrhoea (n = 2), nongonococcal urethritis (n = 19), genital warts (n = 2), molluscum contagiosum (n = 1), no abnormality detected (n = 17). Only 10% (n = 9) of male contacts had urethral symptoms and all sexual contacts were treated for chlamydial infection.
Chlamydia tests were most commonly undertaken in association with cervical smears or a combination of cervical smear and other reason for testing, in accordance with the protocol (see table 2 ). Accordingly, the greatest proportion of positive test results was among females who had been tested for chlamydia in association with a cervical smear (34%, n = 32), followed by women referred for termination of pregnancy (23%, n = 22), and women who reported behavioural risk factors (15%, n = 14).
The mean age of females with confirmed chlamydial infection was 17.26 years (range 14-19 (SD 1.44)), of whom 40 requested no correspondence to their home address (43%). There was no statistically significant eVect of age upon the reason for testing, compliance with follow up procedures, or risk of reinfection. The number of days between the invitation to attend for treatment and actual attendance at the teenage clinic (mean = 9.8 days, range 1-53 (SD 10.69)) was significantly greater for girls aged 16 years or less, compared with older girls ( 2 = 9.2, 3 df, p = 0.03). Most index patients (n=69) attended the clinic immediately to discuss their test result and receive treatment, although between 1-5 recalls were necessary for the remaining 25 women (mean number of recalls 2.04 (SD 1.2)). Subsequent recalls by the nurse coordinator and/or health adviser for follow up assessment after treatment were necessary for 53 index patients, (mean number of interventions 2.25, range 1-6 (SD 1.31)). Following treatment, possible reinfection due to unprotected sex with an untreated male partner was reported by 22 (23%) women.
Discussion
Surveillance data from GUM clinics indicate that young people, particularly females aged 16-19 years have the highest rates of genital chlamydial infection.
1 These data may underestimate the prevalence of infection among this age group since younger sexually active people are less likely than their older counterparts to attend GUM clinics.
14 At the time of study, the only available methods in Nottingham to test for chlamydia were endocervical samples examined by culture or enzyme immunosorbent assay (EIA). The latter was selected for practical reasons of storage and transport of specimens to the laboratory, as the clinic was situated some distance from the laboratory, and many specimens were taken during evening and weekend clinics. The population under study comprised young sexually active women (under 20 years), who frequently reported new sexual partners, and may therefore be expected to have a relatively high prevalence of chlamydial infection. This would tend to reduce the likelihood of false positive test results, resulting in good specificity, further improved by DFA confirmation of positive tests. However, we may expect that owing to the lower sensitivity of EIA, some false negative results were obtained. This problem is being addressed by using a polymerase chain reaction (PCR) based method in future.
In this study of attenders at a teenage family planning clinic, the overall proportion of females tested for chlamydial infection who had positive test results was 11%, although this may be an underestimate of infection among this population because of practical diYculties associated with selection of women for screening on the basis of behavioural factors. Under such circumstances, special consideration must be given to the concerns of young women about a vaginal examination which includes the use of a speculum and cervical swab. 15 There is therefore an urgent need to implement the use of a non-invasive screening test for chlamydia (for example, use of PCR tests for urine samples or vaginal swabs) among this population of teenagers, if they are not to be deterred from future clinic attendance for contraceptive care or, indeed, repeated screening for genital chlamydial infection.
The protocol for this study was developed before the lower age limit for cervical cytological screening was raised to age 20 in accordance with the introduction of quality standards for cervical screening in the United Kingdom 16 ; hence, the high proportion of chlamydia tests performed in association with cervical screening. The proportion of positive chlamydia tests associated with cervical screening was, however, consistent with that reported by Grun et al 2 for women aged under 20 attending for cervical screening/well woman checks in selected general practices in London. In common with other studies of chlamydial infection in the United Kingdom, 5 the proportion of teenage clinic attenders with positive test results was highest among females who were selected for screening because they were seeking termination of pregnancy, or were symptomatic and would have been routinely referred to the GUM clinic.
Notification and treatment of sexual partners is a key component of the control and prevention of genital chlamydial infection. 4 9 The small proportion of male sexual partners who had urethral symptoms in this study supports similar findings reported by Singh and Blackwell, 17 who also highlighted the need for assiduous contact tracing, since the majority of male contacts are asymptomatic. There has, however, been little published research which has examined the eVectiveness of patient management in settings other than GUM clinics. Recent evidence from a Danish study, 18 which compared home sampling with conventional contact tracing for detecting chlamydia in male partners of infected women, showed a relatively low success rate for patient referral of sexual contacts to their general practitioners, compared with non-invasive home testing.
In the United Kingdom, current advice regarding management of patients with genital chlamydia in primary care settings recommends referral to a GUM clinic for follow up. 19 However, there is some evidence to show that only a small proportion of patients diagnosed in general practice are routinely referred to a GUM clinic for follow up and contact tracing. [20] [21] [22] The method and outcome of partner notification (contact tracing) and the subsequent impact on health services are therefore important considerations where screening for chlamydia is undertaken in community based settings.
The model of care developed for this study used a mutually agreed collaborative approach between family planning and GUM specialties, and resulted in the majority (82%) of contacts for whom details were available also receiving epidemiological treatment for chlamydia. This is considerably higher than results for patient referral of male contacts to a GUM clinic by female family planning clinic attenders reported by Gunneberg et al, 23 in which 25% of male partners attended for investigation.
Since there is an increased likelihood of default from follow up at a GUM clinic associated with young people aged 25 years or less, 24 a collaborative approach for the management and care may be of particular value for populations which include a high proportion of young women, as in this study. This is supported by the higher proportion of index patients at the teenage clinic for whom action was complete, compared with the randomly sampled GUM clinic comparison group. The finding that younger girls were more likely to delay than older women when attending for treatment, may be related to their concerns about confidentiality, as evidenced by the high proportion of clinic attenders who did not want any correspondence sent to their home address.
The practical implications of implementing eVective cross referencing systems between community based services and GUM clinics need consideration and will require extra time and resources to ensure success. The need for good liaison between local facilities and opportunities for monitoring compliance of chlamydia positive patients referred by family planning clinics to GUM clinics has previously been recommended 25 and was an essential component of this study. We therefore suggest that the development and evaluation of interventions to control the spread of genital chlamydial infection in the United Kingdom not only include appropriate methods for partner notification but also assess the effectiveness of these activities. 
